Drug Shortage Report for BLEOMYCIN FOR INJECTION

Last updated on 2020-10-17 History
Report ID 125779
Drug Identification Number 02265982
Brand name BLEOMYCIN FOR INJECTION
Common or Proper name Bleomycin for Injection
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) BLEOMYCIN
Strength(s) 15UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAPLEURAL INTRAMUSCULAR INTRAPLEURAL INTRAVENOUS SUBCUTANEOUS
Packaging size 10 mL
ATC code L01DC
ATC description CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-10-16
Actual start date
Estimated end date 2020-11-09
Actual end date
Shortage status Actual shortage
Updated date 2020-10-17
Company comments Fresenius Kabi Canada Ltd. regrets to advise that due to a production delay, we will be encountering a supply interruption on our Bleomycin for Injection, 15 Units, SD Vial, 10 mL. Estimated Stockout Date October 16, 2020. Please note that the stockout date may vary by region, please check your local distribution centre for availability.
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2020-10-17 English Compare
v2 2020-10-06 French Compare
v1 2020-10-06 English Compare